Trial Outcomes & Findings for Characterizing and Addressing Financial Toxicity in AYAs With Cancer (NCT NCT06072833)

NCT ID: NCT06072833

Last Updated: 2026-03-16

Results Overview

This is to assess the feasibility of intervention completion. Intervention completion is defined as participants who have demonstrated contact with community partners at any time before the end of 6 months.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

26 participants

Primary outcome timeframe

Up to 6 months

Results posted on

2026-03-16

Participant Flow

Only patients were considered to be enrolled in this study. The enrollment number and number of participants completed represents only patients.

Participant milestones

Participant milestones
Measure
Participants Eligible (Screed Positive)
Individuals who screen positive will move forward to receive the intervention. This intervention includes partnering with community-based organizations to deliver financial education, connection to resources, and counseling tailored to individual patients and spouses for 6-months. Patient Financial Education / Navigation: The investigator anticipates that this will include a baseline financial assessment and educational content, likely using a virtual platform. Participants will be connected with a PAF case manager. There will be monthly follow-ups to the participant for 6-months to address any financial concerns through additional counseling/navigation.
Overall Study
STARTED
26
Overall Study
COMPLETED
17
Overall Study
NOT COMPLETED
9

Reasons for withdrawal

Reasons for withdrawal
Measure
Participants Eligible (Screed Positive)
Individuals who screen positive will move forward to receive the intervention. This intervention includes partnering with community-based organizations to deliver financial education, connection to resources, and counseling tailored to individual patients and spouses for 6-months. Patient Financial Education / Navigation: The investigator anticipates that this will include a baseline financial assessment and educational content, likely using a virtual platform. Participants will be connected with a PAF case manager. There will be monthly follow-ups to the participant for 6-months to address any financial concerns through additional counseling/navigation.
Overall Study
Withdrawal by Subject
1
Overall Study
Lost to Follow-up
8

Baseline Characteristics

Characterizing and Addressing Financial Toxicity in AYAs With Cancer

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Participants Eligible (Screened Positive)
n=26 Participants
Individuals who screen positive will all move forward to receive the intervention. This intervention includes partnering with community-based organizations to deliver financial education, connection to resources, and counseling tailored to individual patients and spouses for 6-months. Patient Financial Education / Navigation: The investigator anticipates that this will include a baseline financial assessment and educational content, likely using a virtual platform. Participants will be connected with a PAF case manager. There will be monthly follow-ups to the participant for 6-months to address any financial concerns through additional counseling/navigation.
Age, Categorical
<=18 years
1 Participants
n=10 Participants
Age, Categorical
Between 18 and 65 years
25 Participants
n=10 Participants
Age, Categorical
>=65 years
0 Participants
n=10 Participants
Sex: Female, Male
Female
20 Participants
n=10 Participants
Sex: Female, Male
Male
6 Participants
n=10 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
13 Participants
n=10 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
9 Participants
n=10 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
4 Participants
n=10 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=10 Participants
Race (NIH/OMB)
Asian
2 Participants
n=10 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=10 Participants
Race (NIH/OMB)
Black or African American
9 Participants
n=10 Participants
Race (NIH/OMB)
White
4 Participants
n=10 Participants
Race (NIH/OMB)
More than one race
1 Participants
n=10 Participants
Race (NIH/OMB)
Unknown or Not Reported
10 Participants
n=10 Participants

PRIMARY outcome

Timeframe: Up to 6 months

Population: Only AYAs that received the intervention were analyzed for this outcome.

This is to assess the feasibility of intervention completion. Intervention completion is defined as participants who have demonstrated contact with community partners at any time before the end of 6 months.

Outcome measures

Outcome measures
Measure
Participants Eligible (Screened Positive)
n=23 Participants
Individuals who screen positive will move forward to receive the intervention. This intervention includes partnering with community-based organizations to deliver financial education, connection to resources, and counseling tailored to individual patients and spouses for 6-months. Patient Financial Education / Navigation: The investigator anticipates that this will include a baseline financial assessment and educational content, likely using a virtual platform. Participants will be connected with a PAF case manager. There will be monthly follow-ups to the participant for 6-months to address any financial concerns through additional counseling/navigation.
Number of Participants Who Completed the Intervention
21 Participants

PRIMARY outcome

Timeframe: Up to 6 months

This is to measure interest and the need for help by community partners that can provide patient financial education and navigation.

Outcome measures

Outcome measures
Measure
Participants Eligible (Screened Positive)
n=26 Participants
Individuals who screen positive will move forward to receive the intervention. This intervention includes partnering with community-based organizations to deliver financial education, connection to resources, and counseling tailored to individual patients and spouses for 6-months. Patient Financial Education / Navigation: The investigator anticipates that this will include a baseline financial assessment and educational content, likely using a virtual platform. Participants will be connected with a PAF case manager. There will be monthly follow-ups to the participant for 6-months to address any financial concerns through additional counseling/navigation.
Number of Eligible Participants Who Received the Intervention
23 Participants

SECONDARY outcome

Timeframe: Baseline, 6 months

Population: COST scores were analyzed for just those that received the intervention and completed both timepoints (baseline and 6-month).

The COST is a patient-reported outcome measure that describes the financial distress experienced by cancer patients. It is a 11-item questionnaire with a score range of 0-44. Lower COST values indicate higher toxicity. Higher scores indicate lower financial toxicity .

Outcome measures

Outcome measures
Measure
Participants Eligible (Screened Positive)
n=15 Participants
Individuals who screen positive will move forward to receive the intervention. This intervention includes partnering with community-based organizations to deliver financial education, connection to resources, and counseling tailored to individual patients and spouses for 6-months. Patient Financial Education / Navigation: The investigator anticipates that this will include a baseline financial assessment and educational content, likely using a virtual platform. Participants will be connected with a PAF case manager. There will be monthly follow-ups to the participant for 6-months to address any financial concerns through additional counseling/navigation.
Comprehensive Score of Financial Toxicity (COST Measure) Score
Baseline
10.47 score on a scale
Standard Deviation 4.78
Comprehensive Score of Financial Toxicity (COST Measure) Score
6 months
16.53 score on a scale
Standard Deviation 8.58

Adverse Events

Participants Eligible (Screed Positive)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Melissa Beauchemin

Columbia University School Of Nursing

Phone: 212-342-4111

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place